Elevance Health (ELV)Sen. Alan Armstrong disclosed a purchase $1K–$15K
Sen. Alan Armstrong disclosed a purchase of Elevance Health in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 116 days
- Disclosure lag
- Traded
- Mar 27, 2026
- Disclosed
- Jul 21, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 28, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 26, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 26, 2026, Elevance Health, Inc. (the “Company”) announced certain management changes. Among these changes, Peter D. Haytaian will transition from his role as Executive Vice President and President of Carelon, effective May 4, 2026, to devote more time to family commitments.”
- Mar 5, 2026Insider · Their first buy on recordDirector purchased ~$870K of ELV shares in the open market
- Mar 6, 2026InsiderOfficer sold ~$911K of ELV shares in the open market
- Mar 12, 2026InsiderDirector sold ~$7.5K of ELV shares in the open market
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Mar 27, 2026 · this disclosureCongressDisclosed purchase of ELV — reported range $1,001 - $15,000
What came next
- Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.1%
- May 19, 2026InsiderOfficer sold ~$617K of ELV shares in the open market
- Jun 11, 2026InsiderDirector sold ~$61K of ELV shares in the open market
- Jun 12, 2026InsiderOfficer sold ~$149K of ELV shares in the open market
- Jul 15, 2026Company filing · Form 8-K · ResultsReported its results
- Jul 17, 2026Insider · 2 peopleInsiders: 3 purchases (~$1.4M)
How to read Senate eFD periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Elevance Health
For Elevance Health, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 37 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ELV page.
Other recent filings by Sen. Alan Armstrong
- Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
- Senate eFD periodic transaction report at Williams Companies (WMB)Sep 17, 2026
- Senate eFD periodic transaction report at KKR & Co. (KKR)Jul 21, 2026
- Senate eFD periodic transaction report at Globe Life (GL)Jul 21, 2026
- Senate eFD periodic transaction report at Copart (CPRT)Jul 21, 2026
The full history of Sen. Alan Armstrong is on the profile page.
How this filing works
Other disclosures at Elevance Health
- SEC Form 13F-HRAug 20, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its ELV page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
